title: Should we continue to target the platelet-activating factor pathway in septic patients?
authors.forename: Peter C
authors.initials: PC
authors.lastname: Minneci
authors.forename: Katherine J
authors.initials: KJ
authors.lastname: Deans
authors.forename: Steven M
authors.initials: SM
authors.lastname: Banks
authors.forename: Peter Q
authors.initials: PQ
authors.lastname: Eichacker
authors.forename: Charles
authors.initials: C
authors.lastname: Natanson
mesh_terms: D043203:1-Alkyl-2-acetylglycerophosphocholine Esterase / Q000627:therapeutic use*; D018806:APACHE; D006801:Humans; D018805:Sepsis / Q000188:drug therapy* / Q000401:mortality; D015996:Survival Rate
chemical_list: D043203:1-Alkyl-2-acetylglycerophosphocholine Esterase